title: Self-reported hypertension and use of antihypertensive medication among adults - United States, 2005-2009.
abstract: Hypertension affects one third of adults in the United States and is a major risk factor for heart disease and stroke. A previous report found differences in the prevalence of hypertension among racial/ethnic populations in the United States; blacks had a higher prevalence of hypertension, and Hispanics had the lowest use of antihypertensive medication. Recent variations in geographic differences in hypertension prevalence in the United States are less well known. To assess state-level trends in self-reported hypertension and treatment among U.S. adults, CDC analyzed 2005-2009 data from the Behavioral Risk Factor Surveillance System (BRFSS). The results indicated wide variation among states in the prevalence of self-reported diagnosed hypertension and use of antihypertensive medications. In 2009, the age-adjusted prevalence of self-reported hypertension ranged from 20.9% in Minnesota to 35.9% in Mississippi. The proportion reporting use of antihypertensive medications among those who reported hypertension ranged from 52.3% in California to 74.1% in Tennessee. From 2005 to 2009, nearly all states had an increased prevalence of self-reported hypertension, with percentage-point increases ranging from 0.2 for Virginia (from 26.9% to 27.1%) to 7.0 for Kentucky (from 27.5% to 34.5%). Overall, from 2005 to 2009, the prevalence of self-reported hypertension among U.S. adults increased from 25.8% to 28.3%. Among those reporting hypertension, the proportion using antihypertensive medications increased from 61.1% to 62.6%. Increased knowledge of the differences in self-reported prevalence of hypertension and use of antihypertensive medications by state can help in guiding programs to prevent heart disease, stroke, and other complications of uncontrolled hypertension, including those conducted by state and local public health agencies and health-care providers.
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D040343:Behavioral Risk Factor Surveillance System; D005260:Female; D006801:Humans; D006973:Hypertension / Q000188:drug therapy* / Q000453:epidemiology; D008297:Male; D008875:Middle Aged; D015995:Prevalence; D057566:Self Report; D014481:United States / Q000453:epidemiology; D055815:Young Adult
chemical_list: D000959:Antihypertensive Agents
references.citation: Circulation. 2012 Jan 3;125(1):e2-e220
references.pmid: 22179539
references.citation: J Am Soc Hypertens. 2010 Jan-Feb;4(1):32-41
references.pmid: 20374949
references.citation: Stroke. 2006 May;37(5):1171-8
references.pmid: 16556884
references.citation: MMWR Morb Mortal Wkly Rep. 2011 Sep 16;60(36):1248-51
references.pmid: 21918495
references.citation: MMWR Morb Mortal Wkly Rep. 2011 Feb 4;60(4):103-8
references.pmid: 21293325
references.citation: JAMA. 2010 May 26;303(20):2043-50
references.pmid: 20501926
references.citation: JAMA. 2003 May 21;289(19):2560-72
references.pmid: 12748199
references.citation: MMWR Suppl. 2012 Jun 15;61(2):19-25
references.pmid: 22695459
references.citation: MMWR CDC Surveill Summ. 1998 Dec 11;47(5):35-69
references.pmid: 9859955